-
公开(公告)号：US20070202104A1
公开(公告)日：2007-08-30
申请号：US10623039
申请日：2003-07-18
申请人： Subhashis Banerjee , Lori Taylor , Clive Spiegler , Daniel Tracey , Elliot Chartash , Rebecca Hoffman , William Barchuk , Philip Yan , Anwar Murtaza , Jochen Salfeld , Steven Fischkoff
发明人： Subhashis Banerjee , Lori Taylor , Clive Spiegler , Daniel Tracey , Elliot Chartash , Rebecca Hoffman , William Barchuk , Philip Yan , Anwar Murtaza , Jochen Salfeld , Steven Fischkoff
IPC分类号： A61K39/395 , A61K31/405 , A61K31/192 , C07K16/24
CPC分类号： C07K16/241 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K2299/00 , C07K2317/21 , C07K2317/54 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , Y02A50/388 , Y02A50/412
摘要： Methods for treating spondyloarthropathies, including ankylosing spondylitis, using TNFα inhibitors are described.
摘要翻译： 描述了使用TNFα抑制剂治疗脊柱关节病，包括强直性脊柱炎的方法。
-
公开(公告)号：US20130243786A1
公开(公告)日：2013-09-19
申请号：US10623318
申请日：2003-07-18
申请人： Subhashis Banerjee , Lori K. Taylor , Clive E. Spiegler , Daniel Edward Tracey , Elliot K. Chartash , Rebecca S. Hoffman , William T. Barchuk , Philip Yan , Anwar Murtaza , Jochen G. Salfeld , Steven Fischkoff
发明人： Subhashis Banerjee , Lori K. Taylor , Clive E. Spiegler , Daniel Edward Tracey , Elliot K. Chartash , Rebecca S. Hoffman , William T. Barchuk , Philip Yan , Anwar Murtaza , Jochen G. Salfeld , Steven Fischkoff
IPC分类号： A61K39/395 , A61K45/06
CPC分类号： C07K16/241 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K2299/00 , C07K2317/21 , C07K2317/54 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , Y02A50/388 , Y02A50/412
摘要： Methods of treating TNFα-related disorders comprising administering TNFα inhibitors, including TNFα antibodies are described.
摘要翻译： 描述了治疗TNFalpha相关病症的方法，包括给予TNFα抑制剂，包括TNFα抗体。
-
公开(公告)号：US20080193466A1
公开(公告)日：2008-08-14
申请号：US12102682
申请日：2008-04-14
申请人： Subhashis Banerjee , Lori K. Taylor , Clive E. Spiegler , Daniel Edward Tracey , Elliot K. Chartash , Rebacca S. Hoffman , William T. Barchuk , Philip Yan , Anwar Murtaza , Jochen G. Salfeld , Steven Fischkoff
发明人： Subhashis Banerjee , Lori K. Taylor , Clive E. Spiegler , Daniel Edward Tracey , Elliot K. Chartash , Rebacca S. Hoffman , William T. Barchuk , Philip Yan , Anwar Murtaza , Jochen G. Salfeld , Steven Fischkoff
IPC分类号： A61K39/395 , A61P7/06
CPC分类号： C07K16/241 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K2299/00 , C07K2317/21 , C07K2317/54 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , Y02A50/388 , Y02A50/412
摘要： Methods for treating anemia in which TNFα activity is detrimental are described.
摘要翻译： 描述了治疗TNFalpha活性有害的贫血的方法。
-
公开(公告)号：US20150050216A1
公开(公告)日：2015-02-19
申请号：US14326061
申请日：2014-07-08
申请人： Mary Kaye Willian , Martin M. Okun , Rebecca S. Hoffman , Yihua Gu , Lisa E. Melilli , Kenneth B. Gordon , Subhashis Banerjee , Lori K. Taylor , Daniel E. Tracey , Elliot K. Chartash , William T. Barchuk , Philip Yan , Anwar Murtaza , Jochen G. Salfeld , Steven A. Fischkoff , George R. Granneman
发明人： Mary Kaye Willian , Martin M. Okun , Rebecca S. Hoffman , Yihua Gu , Lisa E. Melilli , Kenneth B. Gordon , Subhashis Banerjee , Lori K. Taylor , Daniel E. Tracey , Elliot K. Chartash , William T. Barchuk , Philip Yan , Anwar Murtaza , Jochen G. Salfeld , Steven A. Fischkoff , George R. Granneman
IPC分类号： C07K16/24
CPC分类号： C07K16/241 , A61K2039/505 , A61K2039/54 , A61K2039/545 , C07K2317/21 , C07K2317/76 , Y02A50/388
摘要： The invention provides methods, uses and compositions for the treatment of psoriasis. The invention describes methods and uses for treating psoriasis, wherein a TNFα inhibitor, such as a human TNFα antibody, or antigen-binding portion thereof, is used to treat psoriasis in a subject. Also described are methods for determining the efficacy of a TNFα inhibitor for treatment psoriasis in a subject.
摘要翻译： 本发明提供治疗牛皮癣的方法，用途和组合物。 本发明描述了用于治疗牛皮癣的方法和用途，其中使用TNFα抑制剂，例如人TNFα抗体或其抗原结合部分来治疗受试者的牛皮癣。 还描述了确定受试者中TNFα抑制剂治疗牛皮癣的功效的方法。
-
5.发明申请公开(公告)号：US20130243763A1
公开(公告)日：2013-09-19
申请号：US13903525
申请日：2013-05-28
申请人： Subhashis Banerjee , Lori K. Taylor , Clive E. Spiegler , Daniel Edward Tracey , Elliot Keith Chartash , Rebecca S. Hoffman , William T. Barchuk , Philip Yan , Anwar Murtaza , Jochen G. Salfeld , Steven A. Fischkoff
发明人： Subhashis Banerjee , Lori K. Taylor , Clive E. Spiegler , Daniel Edward Tracey , Elliot Keith Chartash , Rebecca S. Hoffman , William T. Barchuk , Philip Yan , Anwar Murtaza , Jochen G. Salfeld , Steven A. Fischkoff
IPC分类号： A61K39/395
CPC分类号： C07K16/241 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K2299/00 , C07K2317/21 , C07K2317/54 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , Y02A50/388 , Y02A50/412
摘要： Methods of treating TNFα-related disorders comprising administering TNFα inhibitors, including TNFα antibodies are described.
摘要翻译： 描述了治疗TNFalpha相关病症的方法，包括给予TNFα抑制剂，包括TNFα抗体。
-
公开(公告)号：US20090311241A9
公开(公告)日：2009-12-17
申请号：US11645287
申请日：2006-12-22
申请人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas Warne , Angela Kantor , John Elvin , Alexander Duncan , Elaine Derbyshire , Sara Carmen , Stephen Smith , Thor Holtet , Sarah Du Fou
发明人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas Warne , Angela Kantor , John Elvin , Alexander Duncan , Elaine Derbyshire , Sara Carmen , Stephen Smith , Thor Holtet , Sarah Du Fou
IPC分类号： A61K39/395 , A61P37/00 , C07K14/54 , C07K16/24 , G01N33/00
CPC分类号： C07K16/244 , A61K2039/505 , C07K2317/21 , C07K2317/30 , C07K2317/33 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要： Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.
摘要翻译： 公开了特异性结合人白细胞介素-12（hIL-12）的人抗体，优选重组人抗体。 优选的抗体对hIL-12具有高亲和力，并在体外和体内中和hIL-12活性。 本发明的抗体可以是全长抗体或其抗原结合部分。 本发明的抗体或抗体部分可用于检测hIL-12和抑制hIL-12活性，例如在患有hIL-12活性有害的病症的人类受试者中。 用于表达本发明的重组人抗体的核酸，载体和宿主细胞以及合成重组人抗体的方法也包括在本发明中。
-
公开(公告)号：US20120213792A1
公开(公告)日：2012-08-23
申请号：US13418049
申请日：2012-03-12
申请人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida M. Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas W. Warne , Angela Myles , John Gawain Elvin , Alexander Robert Duncan , Elaine Joy Derbyshire , Sara Carmen , Stephen Smith , Thor Las Holtet , Sarah Leila Du Fou
发明人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida M. Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas W. Warne , Angela Myles , John Gawain Elvin , Alexander Robert Duncan , Elaine Joy Derbyshire , Sara Carmen , Stephen Smith , Thor Las Holtet , Sarah Leila Du Fou
IPC分类号： A61K39/395 , A61P1/04 , A61P19/02 , A61P37/00 , A61P17/06
CPC分类号： C07K16/244 , A61K9/0019 , A61K38/208 , A61K39/00 , A61K39/3955 , A61K39/39591 , A61K45/06 , A61K47/20 , A61K47/22 , A61K47/26 , A61K2039/505 , C07K14/5434 , C07K16/00 , C07K16/18 , C07K2317/21 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/94 , Y10S514/863 , Y10S514/885 , Y10S514/886
摘要： Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.
-
公开(公告)号：US20090175857A1
公开(公告)日：2009-07-09
申请号：US12253103
申请日：2008-10-16
申请人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida M. Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas W. Warne , Angela Myles , John Gawain Elvin , Alexander Robert Duncan , Elaine Joy Derbyshire , Sara Carmen , Stephen Smith , Thor Las Holtet , Sarah Leila Du Fou
发明人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida M. Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas W. Warne , Angela Myles , John Gawain Elvin , Alexander Robert Duncan , Elaine Joy Derbyshire , Sara Carmen , Stephen Smith , Thor Las Holtet , Sarah Leila Du Fou
IPC分类号： A61K39/395 , C07K16/18
CPC分类号： C07K16/244 , A61K9/0019 , A61K38/208 , A61K39/00 , A61K39/3955 , A61K39/39591 , A61K45/06 , A61K47/20 , A61K47/22 , A61K47/26 , A61K2039/505 , C07K14/5434 , C07K16/00 , C07K16/18 , C07K2317/21 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/94 , Y10S514/863 , Y10S514/885 , Y10S514/886
摘要： Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.
摘要翻译： 公开了特异性结合人白细胞介素-12（hIL-12）的人抗体，优选重组人抗体。 优选的抗体对hIL-12具有高亲和力，并在体外和体内中和hIL-12活性。 本发明的抗体可以是全长抗体或其抗原结合部分。 本发明的抗体或抗体部分可用于检测hIL-12和抑制hIL-12活性，例如在患有hIL-12活性有害的病症的人类受试者中。 用于表达本发明的重组人抗体的核酸，载体和宿主细胞以及合成重组人抗体的方法也包括在本发明中。
-
公开(公告)号：US20080063634A1
公开(公告)日：2008-03-13
申请号：US11645287
申请日：2006-12-22
申请人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas Warne , Angela Kantor , John Elvin , Alexander Duncan , Elaine Derbyshire , Sara Carmen , Stephen Smith , Thor Holtet , Sarah Du Fou
发明人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas Warne , Angela Kantor , John Elvin , Alexander Duncan , Elaine Derbyshire , Sara Carmen , Stephen Smith , Thor Holtet , Sarah Du Fou
IPC分类号： A61K39/395 , A61P37/00 , C07K14/54 , C07K16/24 , G01N33/00
CPC分类号： C07K16/244 , A61K2039/505 , C07K2317/21 , C07K2317/30 , C07K2317/33 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要： Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.
摘要翻译： 公开了特异性结合人白细胞介素-12（hIL-12）的人抗体，优选重组人抗体。 优选的抗体对hIL-12具有高亲和力，并在体外和体内中和hIL-12活性。 本发明的抗体可以是全长抗体或其抗原结合部分。 本发明的抗体或抗体部分可用于检测hIL-12和抑制hIL-12活性，例如在患有hIL-12活性有害的病症的人类受试者中。 用于表达本发明的重组人抗体的核酸，载体和宿主细胞以及合成重组人抗体的方法也包括在本发明中。
-
10.发明授权Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same 有权结合人IL-12的P40亚基的人抗体及其使用方法公开(公告)号：US09035030B2
公开(公告)日：2015-05-19
申请号：US13401559
申请日：2012-02-21
申请人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida M. Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas W. Warne , Angela Myles , John Gawain Elvin , Alexander Robert Duncan , Elaine Joy Derbyshire , Sara Carmen , Stephen Smith , Thor Las Holtet , Sarah Leila Du Fou
发明人： Jochen Salfeld , Michael Roguska , Michael Paskind , Subhashis Banerjee , Daniel Tracey , Michael White , Zehra Kaymakcalan , Boris Labkovsky , Paul Sakorafas , Geertruida M. Veldman , Amy Venturini , Angela Widom , Stuart Friedrich , Nicholas W. Warne , Angela Myles , John Gawain Elvin , Alexander Robert Duncan , Elaine Joy Derbyshire , Sara Carmen , Stephen Smith , Thor Las Holtet , Sarah Leila Du Fou
IPC分类号： C07K16/24 , C12P21/08 , A61K39/395 , A61K39/00 , C07K16/18 , C07K16/00 , C07K14/54 , A61K38/20
CPC分类号： C07K16/244 , A61K9/0019 , A61K38/208 , A61K39/00 , A61K39/3955 , A61K39/39591 , A61K45/06 , A61K47/20 , A61K47/22 , A61K47/26 , A61K2039/505 , C07K14/5434 , C07K16/00 , C07K16/18 , C07K2317/21 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/94 , Y10S514/863 , Y10S514/885 , Y10S514/886
摘要： Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.
摘要翻译： 公开了特异性结合人白细胞介素-12（hIL-12）的人抗体，优选重组人抗体。 优选的抗体对hIL-12具有高亲和力，并在体外和体内中和hIL-12活性。 本发明的抗体可以是全长抗体或其抗原结合部分。 本发明的抗体或抗体部分可用于检测hIL-12和抑制hIL-12活性，例如在患有hIL-12活性有害的病症的人类受试者中。 用于表达本发明的重组人抗体的核酸，载体和宿主细胞以及合成重组人抗体的方法也包括在本发明中。
-
-
-
-
-
-
-
-
-
搜索结果
26 条记录 (耗时 0.059 秒)
